The Alzheimer’s debate may not seem positive, but AC Immune’s CEO promises it’s been a breakthrough year
The Alzheimer’s debate may not seem positive, but AC Immune’s [...]
The Alzheimer’s debate may not seem positive, but AC Immune’s [...]
No data, no problem. Senti will go public in $296M [...]
Forbion arms biotech to stop sudden cardiac death, leading $35M [...]
Novartis suffers shock setback as Xolair successor fails phase 3 [...]
Roche’s Spark unit blueprints $575M gene therapy manufacturing center in [...]
Precisely targeting liver cancer with logic-gated gene therapy aliu Thu, [...]
Abbott gifts $1M to Howard University in effort to diversify [...]
FHI Clinical acquires South African CRO to expand global footprint [...]
Turns out Galera’s radiotherapy complication drug did work after all, [...]
Preventing cancer metastasis by keeping dormant tumor cells asleep with [...]